Top news from MedWatch this week
![Photo: MedWatch](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12791283.ece/ALTERNATES/schema-16_9/doc7eok1wt4jdl13ye5emaw.jpg)
Monday
EU watchdog criticizes European vaccine procurement, urges stronger negotiations in future
Novo Nordisk and Microsoft to collaborate on drug development using AI
GN Group’s staggering debt concerns investors
Tuesday
Novo Nordisk brings forward salary regulations for 50,000 employees due to increasing inflation
WSA and Sony enter OTC partnership
WS Audiology wants to benefit from Sony’s brand and consumer trust
Analyst sees logic in WSA and Sony partnership, but lacks faith in OTC market
Novo Nordisk says Microsoft partnership does more than cut costs
Wednesday
Sonova wins big with Veterans Affairs in August, as Danish manufacturers all drop
Global pharma firms waver on Japan due to drug pricing and regulation
Thursday
Eli Lilly boasts of high demand for new diabetes drug
Employment researcher: Novo Nordisk salary advances are part of retention strategy
Sensorion initiates study of hearing loss therapy candidate
Friday
CHMP recommends approval of 12 drugs at September meeting
CHMP supports label extension of Leo Pharma’s atopic eczema treatment
Sanofi-Astrazeneca preventive RSV drug recommended for approval by CHMP